Medicare may cover Wegovy or Zepbound, but the route depends on why the medicine is prescribed and whether you meet the coverage rules. The temporary Medicare GLP-1 Bridge offers certain eligible people weight-management drugs for a $50 monthly copay. It is separate from ordinary Part D drug coverage.
If you’ve heard both “Medicare doesn’t cover weight-loss drugs” and “you can get them for $50,” the missing piece is which coverage route applies to you. Start there before comparing prices or changing plans.
Program details checked November 11, 2026. This guide explains coverage, not whether a medicine is right for you.
Two routes that should not be confused
A GLP-1 medicine prescribed for a use coverable under Part D follows your drug plan’s coverage process. The Bridge is for eligible weight-management use that would not otherwise be available through Part D. It runs from July 1, 2026 through December 31, 2027. CMS explains how the Bridge works.
A Part D denial, high copay or formulary omission does not automatically make you Bridge-eligible. A Part D-coverable use still follows Part D, including its exception process. Read CMS’s plan guidance.
How do you check whether the Bridge may fit?
Start with Medicare’s official eligibility tool. It asks about your Medicare drug coverage, previous GLP-1 coverage and health history. The program has clinical requirements and exclusions; a screening answer or prescription alone does not establish that you qualify.
Your prescriber should check the current requirements and the coverage route for your actual prescription. Bring these questions to the conversation:
- What is this medicine being prescribed to treat, and which coverage route applies?
- Does my Medicare drug coverage and previous GLP-1 coverage affect eligibility?
- What information and authorization are still needed before the pharmacy can fill it under that route?
Use the official screening guidance with your prescriber rather than interpreting a diagnosis from a general article. CMS’s provider guidance explains the authorization process and the prescriber’s responsibilities. Keep health details within your care team’s or Medicare’s appropriate channels.
Which medicines and forms are listed?
Medicare.gov currently lists Foundayo tablets, Wegovy injections or tablets, and Zepbound KwikPen. Single-dose Zepbound pens and vials are excluded from the Bridge. Confirm the exact product and form with the pharmacy. Check Medicare’s current covered-drug list.
What will you pay?
The Bridge copay is $50 for a 28-day or 30-day supply, depending on the medicine. The Part D deductible does not apply, and the copay does not count toward your Part D out-of-pocket limit. Extra Help does not reduce it. Bridge prescriptions also cannot be included in the Medicare Prescription Payment Plan. CMS describes these payment rules.
How to start the conversation
- Ask your prescriber to review the prescription’s purpose, your diagnoses, Medicare drug coverage and any GLP-1 use through Part D.
- If the Bridge may fit, the prescriber sends the prescription to the pharmacy for Bridge processing.
- The pharmacy submits the claim and requests the required prior authorization from the prescriber. A Part D denial is not required first.
- Confirm the authorization result, exact medicine and form, and amount due before relying on coverage.
CMS describes the prescription and authorization sequence.
Medicare also requires the prescriber to certify use as part of a diet-and-exercise lifestyle program. Its official coverage page includes a screening tool and help through 1-800-MEDICARE (1-800-633-4227; TTY 1-877-486-2048).
Common questions
Does a prescription guarantee the $50 price?
No. The prescription, program eligibility and required authorization are separate steps. Ask the office and pharmacy what is still outstanding.
Should I switch my Part D plan just to get the Bridge?
Don’t assume a switch is needed. The Bridge uses a separate payment route. Review your whole drug list and existing coverage before changing plans; our Part D basics guide explains the broader coverage.
Is the Bridge permanent?
No. CMS currently describes it as temporary through December 31, 2027. Recheck the official program before making longer-term cost assumptions.
Have a general question about this guide? Contact ShieldWise. Ask your prescriber about treatment and clinical requirements, Medicare about the Bridge program, and your plan about Part D coverage. Please keep medical records and Medicare numbers out of the general contact form.
This article provides general education, not individual insurance, medical, legal or tax advice. Benefits, costs, availability and enrollment rights depend on the coverage and applicable rules. Confirm your situation with the official program, plan administrator or a qualified professional. ShieldWise is not affiliated with or endorsed by Medicare or the federal government.